Garg B P
Arch Neurol. 1982 Jun;39(6):376-7. doi: 10.1001/archneur.1982.00510180054014.
Sporadic, autosomal recessive and dominant forms of dystonia musculorum deformans have been recognized. This communication reports the results of treatment of six patients with this condition. Two patients with the recessive form responded to levodopa therapy. Three patients who responded to carbamazepine therapy probably have the dominant form. In one patient, response to carbamazepine therapy was equivocal. It is suggested that such therapeutic responsiveness may reflect underlying biochemical differences in the recessive and dominant forms of the disease.
肌张力障碍畸形的散发型、常染色体隐性和显性形式已得到确认。本报告介绍了6例该病症患者的治疗结果。两名隐性形式的患者对左旋多巴治疗有反应。三名对卡马西平治疗有反应的患者可能为显性形式。一名患者对卡马西平治疗的反应不明确。有人认为，这种治疗反应性可能反映了该疾病隐性和显性形式潜在的生化差异。
